000			02209nam a22003855i 4500
001			76532
003			ES-MaUEC
005			20230202102119.0
007			cr nn 008mamaa
008			131119s2014 gw s 000 0 eng d
020			_a9783642412936
040			_aES-MaUEC
050		4	_aK1519.B54 _bS76 2014 EB
082	0	4	_a611.01816
100	1		_aStorz, Ulrich _d1969- _0no2012041875 _948433
245	1	0	_aBiopatent Law : _bEuropean vs. US Patent Law _cby Ulrich Storz, Martin Quodbach, Scott D. Marty, Derek E. Constantine, Matthew Parker.
264		1	_aBerlin, Heidelberg _bSpringer International Publishing _c2014
300			_a1 recurso en línea (VIII, 69 p.) _b7 ilustraciones, 5 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aSpringerBriefs in Biotech Patents _x2192-9904
520	3		_aSpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents
942			_2lcc _cLE
988			_aEBOOK, EBSPRINGERrevisando
650		7	_aBiotecnología _xPatentes _9329677 _0comprobar BNE20021848258 _2embne
700	1		_aQuodbach, Martin _0no2014066903 _948434
700	1		_aMarty, Scott D. _0no2014066909 _948435
700	1		_aConstantine, Derek E. _0no2014066950 _948436
700	1		_aParker, Matthew _0Local _940244 _0comprobar BNE20070047629
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-41293-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12821500 _b17-10-17 _c01-10-14
998			_am _a_alco _a_vill _b17-10-17 _cm _dz _eu _feng _ggw _h0
945			_aK1519 .B54 S762014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11550715 _z06-04-17
999			_c76532 _d76532 _x1